Rounds / AOI Biosciences
AB
AOI Biosciences raises ¥500M (Undisclosed)
Antibody testing and drug discovery for infertility and recurrent pregnancy loss.
- Company
- AOI Biosciences
- Reported
- 14 Sept 2026 · that week's brief
- Stage
- Undisclosed · Other
- Amount
- ¥500M1 · as announced: 「約5億円」
- Breakdown
- Equity not disclosed separately
- Status
- In scopeNot yet registry-confirmed
- Notes
- Transaction total includes secondary share transfer; split not disclosed
- Investors
- Not listed in our summary; see source
- Sector
- BiotechDeep tech
- Source
- Primary release (PR TIMES) · BRIDGE coverage
1 ≈ ~$3.23M at the ECB reference rate on 2026-09-14 (¥1 = $0.00647). Yen is the figure of record. Methodology
Get the weekly brief
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →
Every Japanese funding round worth knowing, in one English email. Free. Subscribe on Substack →